Informatie:
Fout:
ID
13996
Beschrijving
Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01489722
Link
https://clinicaltrials.gov/show/NCT01489722
Trefwoorden
Versies (1)
- 21-03-16 21-03-16 -
Geüploaded op
21 maart 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Myeloid Leukemia NCT01489722
Eligibility Acute Myeloid Leukemia NCT01489722
- StudyEvent: Eligibility
Similar models
Eligibility Acute Myeloid Leukemia NCT01489722
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Age
Item
males or females at least 18 years of age
boolean
C0001779 (UMLS CUI [1])
Acute myelogenous leukemia in relapse
Item
Patients with relapsed or refractory acute myelogenous leukemia (aml) or aml secondary to myelodysplastic syndromes, myeloproliferative neoplasm, or chronic myelogenous leukemia
boolean
C2367456 (UMLS CUI [1])
ECOG performance status
Item
Eastern oncology cooperative group (ecog) performance status 0-2 and considered likely to complete at least 4 weeks of therapy
boolean
C1520224 (UMLS CUI [1])
Mild Adverse Event
Item
With the exception of alopecia, any unresolved toxicities from prior therapy greater than ctcae grade 1 at the time of starting study treatment.
boolean
C1513302 (UMLS CUI [1])
Systemic disease
Item
As judged by the investigator, any evidence of severe or uncontrolled systemic diseases, including uncontrolled hypertension, active bleeding diatheses, or active infection including hepatitis b, hepatitis c and hiv.
boolean
C0442893 (UMLS CUI [1])
C2711110 (UMLS CUI [2])
C0741554 (UMLS CUI [3])
C2711110 (UMLS CUI [2])
C0741554 (UMLS CUI [3])
Heart Disease
Item
Active heart disease including myocardial infarction within the last 3 months, symptomatic coronary artery disease, clinically significant arrhythmias not controlled by medication or uncontrolled congestive heart failure
boolean
C0018799 (UMLS CUI [1])
Therapeutic immunosuppression
Item
Prior allogeneic transplant requiring immunosuppressive therapy (patients with prior allogeneic transplants who remain clinically stable for ≥ 2 weeks or more off immunosuppressive therapy, are eligible)
boolean
C0021079 (UMLS CUI [1])
Total white blood count
Item
White blood cell count ≥ 100,000/mm3 (100x10*9/l)
boolean
C1271681 (UMLS CUI [1])
DM 1
Item
type 1 diabetes or uncontrolled type ii diabetes
boolean
Hba1c
Item
hba1c ≥8% or fasting blood glucose >160 mg/dl (>8.9 mmol/l)
boolean
C0019018 (UMLS CUI [1])
Total cholesterol
Item
Baseline fasting total cholesterol >300 mg/dl (>7.75 mmol/l)
boolean
C0543421 (UMLS CUI [1])